UCHL5 and ovarian serous adenocarcinoma: Our analysis of several human cancers from the cBioportal database [38] revealed that gene alterations are frequent in UCHL5 including amplification or mutation in several types of human cancer, specifically in 9.8% of breast cancer and 7% of high grade serous ovarian cancer (Figure 1A).